Industrial Hemp Operations Expansion Continues To Solidify Itself As An Agricultural Commodity As Reports Show Sales North Of $500Mil Annually

CORAL SPRINGS, Florida, August 23, 2016 /PRNewswire/ --

With approved pilot programs and increased research funding, the industrial hemp sector aims to continue its success both financially and as a whole as it moves towards greater acceptance in society.  Precise data are not available on the size of the U.S. market for hemp-based products, but according to Federation of American Scientists (FAS.org)  current industry estimates report annual sales at more than $580 million annually.  Hemp, cannabis and legal marijuana advancements are drawing more and more legit companies into the industry as the market has shown to keep close watch of Green Cures & Botanical Distribution Inc. (OTC Pink: GRCU), Medical Marijuana, Inc. (OTC Pink: MJNA), Greengro Technologies, Inc. (OTC Pink: GRNH), Hemp, Inc. (OTC Pink: HEMP) and PharmaCyte Biotech, Inc. (OTCQB: PMCB).

Green Cures & Botanical Distribution Inc. (OTC: GRCU), a medical marijuana and industrial hemp products innovator announced today that the company has finalized and closed the land lease deal to lease 20 acres of agricultural land in the Adelanto, CA area.

GRCU is well on its way to be a part of the major movement in the medical marijuana sector in the cultivation area. Now that the company has closed the leasing agreement, the company can lock down and finalize the agreement with an already established licensed grower.

Read the full GRCU Press Release at: http://financialnewsmedia.com/profiles/grcu.html

As previously stated, high profile celebrities have shown major interest to cultivate cannabis in the city of Adelanto and GRCU will be established as one of the first one-stop-shops for this huge economic opportunity alongside of these well-known entertainment celebrities.   Marijuana, although legal in only a few states in the US, is one of the most popular intermediaries for Americans, who, in 2015 spent more on legal marijuana ($3.4B) than they did on Oreos ($711M). As the herb's illicit reputation is shed, it will become an ingredient engrained in our lives like any other legal and socially acceptable go-between.

In other news and trading activity from around the industry of note in the markets:

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States,  announced that at The San Francisco Money Show's Cannabis Investing Symposium, which the Company is sponsoring, Medical Marijuana, Inc. CEO Dr. Stuart Titus will speak to investors about current global cannabis industry trends, investment opportunities and how the Company's diversified portfolio of cannabis companies and brands are capitalizing on the current cannabis revolution.

Greengro Technologies, Inc. (OTC: GRNH) a world-class provider of eco-friendly green technologies, recently announced this month that the Company's new business division, CBDVentures, plans for its new selection of hemp-infused fruit flavored CBD nectars.  The Company's CBD Energy Nectar Beverage line is all natural and enhanced with hemp, guarana, ginseng, and a sweet savor of robust authenticity. The nectars deliver a tasty blast of fruit flavor coupled with an energy boost specially formulated to create a gratification that fully lives up to the very definition of its name; Amrita: "Immortality" and Nectar: "The flavored drink of the gods".

Hemp, Inc. (OTC: HEMP) executives announced that its wholly owned subsidiary, Industrial Hemp Manufacturing, LLC, sponsored the "hempcentric" festival, HEMP X, this past weekend at the Highland Brewing Company in Asheville, North Carolina. The family-friendly free event, hosted Asheville-area farmers, entrepreneurs, and other small business owners in an effort to highlight the economic benefits of growing industrial hemp while educating Americans on the importance of hemp and the multiple uses and benefits of industrial hemp.

PharmaCyte Biotech, Inc. (OTC: PMCB) closed up at $0.0415 on high volume trading activity of over 13.9Million shares traded by the market close.  PMCB announced back in July that a recently published scientific article supports PharmaCyte's ongoing research efforts that concern medical uses for constituents of Cannabis known as cannabinoids.

DISCLAIMER:  FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein.  FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNMG is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNMG has been compensated three thousand nine hundred dollars for news coverage of the current press release issued by Green Cures & Botanical Distribution Inc. by a non-affiliated third party.  FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
Phone:  +1-954-345-0611
URL: http://www.financialnewsmedia.com